Enjoy complimentary customisation on priority with our Enterprise License!
The liposomal products market size is forecast to increase by USD 3.99 billion at a CAGR of 10.87% between 2023 and 2028. The growth of the market depends on several factors, including the rising incidence of fungal disorders, the growing prevalence of cancer cases, and many side effects associated with cancer treatment. However, late diagnosis and poor survival rates of patients with cancer are major challenges in the liposome drug delivery market. Companies are increasingly focussing on the market trends such as strategic alliances, and rising adoption of quality by design (QbD) over traditional processes to overcome the challenges.
It also includes an in-depth analysis of market trends and analysis, market growth analysis and challenges. Furthermore, the report includes historic market data from 2018 - 2022.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.